Drug intelligence / Profile preview

Flavovir

Development stage
Unknown
Lead developer
Ecopharm
Modality
Small Molecules
Administration
Oral
01

Overview

Flavovir is a direct-acting antiviral herbal extract developed by Ecopharm for the treatment and prevention of influenza and acute respiratory viral infections (ARVI) in children, including newborns. Formulated as an oral syrup, the drug contains a specific complex of flavonoids that inhibit viral replication by directly blocking key enzymes, specifically viral DNA polymerase and thymidine kinase. In addition to its direct antiviral effects, Flavovir induces the synthesis of endogenous alpha- and gamma-interferons to physiologically active levels, thereby enhancing the host's innate immune response. It has demonstrated inhibitory activity against a broad spectrum of DNA and RNA viruses, including influenza and herpes viruses, and is typically administered twice daily.

Brand names
Flavovir
02

Targets

Human immunodeficiency virus type 1 reverse transcriptaseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))Mpro (3C-like proteinase of SARS-CoV-2)IFNG (Interferon gamma)DNA polymerase familyIFN-α (Interferon alpha-7)NeuraminidaseRdRp (Coronavirus RNA-dependent RNA polymerase)

Beyond the preview

Go deeper on Flavovir.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavovir.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call